Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Ageing Research Reviews|April 5, 2024
A critical appraisal of blood-based biomarkers for Alzheimer's diseaseSimone Lista, Mark Mapstone, Filippo Caraci, et al.
Journal of Alzheimer'S Disease : JAD|July 13, 2012
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's diseasePascale Fehlbaum-Beurdeley, Olivier Sol, Laurent Désiré, et al.
Alzheimer'S Research & Therapy|June 3, 2015
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric studyJulien Dumurgier, Susanna Schraen, Audrey Gabelle, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2010
Memantine in behavioral variant frontotemporal dementia: negative resultsMartine Vercelletto, Claire Boutoleau-Bretonnière, Christelle Volteau, et al.
Frontiers in Aging Neuroscience|March 7, 2019
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß<sub>1-42</sub>, and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Frontiers in Aging Neuroscience|October 18, 2018
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ<sub>1-42</sub> and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentAudrey Gabelle, Marwan N Sabbagh, Timo Grimmer, et al.
Sleep Medicine|April 15, 2011
Increased perfusion in supplementary motor area during a REM sleep behaviour episodeYves Dauvilliers, Dauvilliers Yves, Vincent Boudousq, et al.
Frontiers in Aging Neuroscience|January 27, 2023
Impact of multidomain preventive strategies on functional brain connectivity in older adults with cognitive complaint: Subset from the Montpellier center of the ancillary MAPT-MRI studyLisa Perus, Jean-François Mangin, Jérémy Deverdun, et al.
Journal of Neurology|November 7, 2022
Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analysesSusana López-Ortiz, Simone Lista, Pedro L Valenzuela, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Ageing Research Reviews|April 5, 2024
A critical appraisal of blood-based biomarkers for Alzheimer's diseaseSimone Lista, Mark Mapstone, Filippo Caraci, et al.
Journal of Alzheimer'S Disease : JAD|July 13, 2012
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's diseasePascale Fehlbaum-Beurdeley, Olivier Sol, Laurent Désiré, et al.
Alzheimer'S Research & Therapy|June 3, 2015
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric studyJulien Dumurgier, Susanna Schraen, Audrey Gabelle, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2010
Memantine in behavioral variant frontotemporal dementia: negative resultsMartine Vercelletto, Claire Boutoleau-Bretonnière, Christelle Volteau, et al.
Frontiers in Aging Neuroscience|March 7, 2019
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß<sub>1-42</sub>, and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Frontiers in Aging Neuroscience|October 18, 2018
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ<sub>1-42</sub> and Tau Proteins in Elderly Patients With Mild Cognitive ImpairmentEmmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentAudrey Gabelle, Marwan N Sabbagh, Timo Grimmer, et al.
Sleep Medicine|April 15, 2011
Increased perfusion in supplementary motor area during a REM sleep behaviour episodeYves Dauvilliers, Dauvilliers Yves, Vincent Boudousq, et al.
Frontiers in Aging Neuroscience|January 27, 2023
Impact of multidomain preventive strategies on functional brain connectivity in older adults with cognitive complaint: Subset from the Montpellier center of the ancillary MAPT-MRI studyLisa Perus, Jean-François Mangin, Jérémy Deverdun, et al.
Journal of Neurology|November 7, 2022
Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analysesSusana López-Ortiz, Simone Lista, Pedro L Valenzuela, et al.
Pageof 18